Quarterly report pursuant to Section 13 or 15(d)

SELECTED FINANCIAL STATEMENT LIABILITIES (Details)

v3.24.3
SELECTED FINANCIAL STATEMENT LIABILITIES (Details) - USD ($)
$ in Thousands
Sep. 30, 2024
Dec. 31, 2023
Accounts payable:    
Clinical and regulatory expenses $ 677 $ 696
Professional fees 975 721
Selling expenses 2,477 1,498
Manufacturing costs 837 914
Non-employee director compensation 945 766
Other vendors 578 518
Total accounts payable 6,489 5,113
Accrued interest payable, related parties 823 542
Accrued interest payable 3,531 3,122
Accrued expenses:    
Payroll expenses 599 1,270
Government rebates and other rebates 7,010 5,881
Due to customers   844
Other accrued expenses 255 179
Total accrued expenses 7,864 8,174
Total accounts payable and accrued expenses $ 18,707 $ 16,951